GeneFerm Biotechnology Co., Ltd.
1796.TWO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.22B
Close$
$-11.38
138.6% downside
Current Fair Value
138.6% downsideOvervalued by 138.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.22 Billion |
|---|---|
| Enterprise Value | $1.27 Billion |
| Dividend Yield | $0.70 (2.37%) |
| Earnings per Share | $0.7 |
| Beta | 0.09 |
| Outstanding Shares | 41,460,000 |
Return
| Return on Equity | 2.18% |
|---|---|
| Return on Assets | 1.35% |
| Return on Invested Capital | 2.21% |
Valuation & Multiples
| P/E Ratio | 71.12 |
|---|---|
| PEG | 46.51 |
| Price to Sales | 1.84 |
| Price to Book Ratio | 1.64 |
| Enterprise Value to Revenue | 1.91 |
| Enterprise Value to EBIT | 53.47 |
| Enterprise Value to Net Income | 74 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.42 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About GeneFerm Biotechnology Co., Ltd.
288 employees
CEO: Jinde Jin GeneFerm Biotechnology Co., Ltd. specializes in the development, production, and global distribution of fermented health and wellness products, serving both the Taiwanese domestic market and international clients. The company's extensive...